A phase II study of perioperative S-1 combined with weekly docetaxel in patients with locally advanced gastric cancer: Clinical and pharmacogenetic results

被引：0

作者：

Park, Sook Ryun

Kim, Young Woo

Ryu, Keun Won

Lim, Hyeong-Seok

Lee, Jun Ho

Kong, Sun-Young

Kim, Mi-Jung

Choi, Mihee

Park, Young Iee

机构：

[1] Natl Canc Ctr, Res Inst & Hosp, Ctr Gastr Canc, Goyang, Gyeonggi, South Korea

[2] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Clin Pharmacol & Therapeut, Seoul, South Korea

[3] Natl Canc Ctr, Res Inst & Hosp, Ctr Clin Serv, Goyang, Gyeonggi, South Korea

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2013年 / 31卷 / 15期

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

4114

引用

页数：2

共 50 条

[1] A phase II study of perioperative S-1 combined with weekly docetaxel in patients with locally advanced gastric carcinoma: clinical outcomes and clinicopathological and pharmacogenetic predictors for survival
Young-Woo Kim
Mi-Jung Kim
Keun Won Ryu
Hyeong-Seok Lim
Jun Ho Lee
Sun-Young Kong
Jong Seok Lee
Il Ju Choi
Chan Gyoo Kim
Jong Yeul Lee
Soo-Jeong Cho
Myeong-Cherl Kook
Young-Iee Park
Seok-Ki Kim
Sook Ryun Park
Gastric Cancer, 2016, 19 : 586 - 596
[2] A phase II study of perioperative S-1 combined with weekly docetaxel in patients with locally advanced gastric carcinoma: clinical outcomes and clinicopathological and pharmacogenetic predictors for survival
Kim, Young-Woo
Kim, Mi-Jung
Ryu, Keun Won
Lim, Hyeong-Seok
Lee, Jun Ho
Kong, Sun-Young
Lee, Jong Seok
Choi, Il Ju
Kim, Chan Gyoo
Lee, Jong Yeul
Cho, Soo-Jeong
Kook, Myeong-Cherl
Park, Young-Iee
Kim, Seok-Ki
Park, Sook Ryun
GASTRIC CANCER, 2016, 19 (02) : 586 - 596
[3] Phase I/II study of S-1 combined with weekly docetaxel in patients with metastatic gastric carcinoma
S R Park
H K Kim
C G Kim
I J Choi
J S Lee
J H Lee
K W Ryu
Y-W Kim
J-M Bae
N K Kim
British Journal of Cancer, 2008, 98 : 1305 - 1311
[4] Phase I/II study of S-1 combined with weekly docetaxel in patients with metastatic gastric carcinoma
Park, S. R.
Kim, H. K.
Kim, C. G.
Choi, I. J.
Lee, J. S.
Lee, J. H.
Ryu, K. W.
Kim, Y-W
Bae, J-M
Kim, N. K.
BRITISH JOURNAL OF CANCER, 2008, 98 (08) : 1305 - 1311
[5] Phase I/II study of docetaxel and S-1 in patients with advanced gastric cancer
K Yamaguchi
T Shimamura
I Hyodo
W Koizumi
T Doi
H Narahara
Y Komatsu
T Kato
S Saitoh
T Akiya
M Munakata
Y Miyata
Y Maeda
H Takiuchi
S Nakano
T Esaki
F Kinjo
Y Sakata
British Journal of Cancer, 2006, 94 : 1803 - 1808
[6] Phase II study of a triplet regimen of S-1 combined with irinotecan and oxaliplatin in patients with metastatic gastric cancer: clinical and pharmacogenetic results
Park, S. R.
Kong, S. -Y.
Rhee, J.
Park, Y. -I.
Ryu, K. W.
Lee, J. H.
Kim, Y. -W.
Choi, I. J.
Kim, C. G.
Lee, J. Y.
Cho, S. -J.
Kim, N. K.
ANNALS OF ONCOLOGY, 2011, 22 (04) : 890 - 896
[7] Phase II study of a triplet regimen of S-1 combined with irinotecan and oxaliplatin in patients with metastatic gastric cancer: Clinical and pharmacogenetic results
Park, Sook Ryun
Kong, Sun-Young
Cho, Hyo Jin
Park, Young Lan
Lee, Jun Ho
Ryu, Keun Won
Kim, Young-Woo
Choi, Ii Ju
Kim, Chan Gyoo
Lee, Jong Yeul
Cho, Soo-Jeong
Lee, Jong Seok
Kook, Myeong-Cherl
Park, Young-Lee
Lee, Keun-Wook
Kim, Noe Kyeong
CANCER RESEARCH, 2010, 70
[8] Phase II study of docetaxel, oxaliplatin and S-1 (DOS) for patients with advanced gastric cancer
Zang, D.
Kang, Y.
Ryu, B.
Ryu, M.
Lee, S.
Kim, H.
Kim, J.
Jung, J.
Kwon, J.
Kim, H.
EJC SUPPLEMENTS, 2009, 7 (02): : 375 - 375
[9] Results of a phase II multicenter study of neoadjuvant S-1 and irinotecan in patients with locally advanced gastric cancer
Terashima, M.
Saze, Z.
Hosotani, R.
Takahashi, M.
Takagane, A.
Hachiya, O.
Koeda, K.
Matsui, S.
Ohashi, W.
Gotoh, M.
JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
[10] Phase I study of combination therapy with S-1 and weekly docetaxel for advanced gastric cancer
Ozaki, Tomohiro
Tamura, Kenji
Satoh, Taroh
Kurata, Takayasu
Shimizu, Toshio
Miyazaki, Masaki
Okamoto, Isamu
Nakagawa, Kazuhiko
Fukuoka, Masahiro
ANTICANCER RESEARCH, 2007, 27 (4C) : 2657 - 2665

← 1 2 3 4 5 →